Search
A new database of medicines will provide African, South American and Southeast Asian governments with technological data to use in identifying fake medicine. The Promoting the Quality of Medicines (PQM) program developed by USAID and the U.S. Pharmacopeial Convention (USP) has launched a new public database of drugs collected and analyzed in collaboration with government agencies and NGOs in Africa,…
Read MoreRECALLED: THE BEST Enhancement SupplementPicture by USFDA via Flickr. This is a reprint of the FDA alert. March 28, 2011 – AVNS Inc announced today it is voluntarily recalling THE BEST Enhancer Supplement. AVNS Inc is conducting a voluntary recall after being informed by their manufacturer, Drive Total Energy, that the Food and Drug Administration (FDA) lab analyses found that…
Read MoreImage courtesy of Finnish Customs
Read MoreThe FDA’s Office of Criminal Investigations reported that 72 cases had been opened up in 2010, 11% more than the year before, and at 3-5 times what was reported a decade ago. Reports Pharmaceutical Commerce, Deputy Administrator Dr. Ilisa Bernstein cited those figures during a presentation for the Pew Prescription Project in Washington, DC in early March. The FDA cautions…
Read MoreThis is a reprint of the FDA alert. ISSUE: FDA lab analysis of X-Hero found the product contains sulfosildenafil, the analogue of the active ingredient of an FDA-approved drug used to treat erectile dysfunction (ED), making X-Hero an unapproved drug. In addition, FDA analysis of Male Enhancer sample found the product contains tadalafil, the active ingredient of an FDA-approved drug…
Read MorePeruvian officials have confiscated 20 tons of fake medication since 2007. 30% of the fakes confiscated were counterfeit antibiotics and another 30% fraudulent analgesics. Peru’s General Agency for Medicine and Drugs (Digemid) reported that antibiotics, analgesics and anti-inflammatories are the most fake medications in Peru, reported Living In Peru. “What is most often faked are medicines that cure common illnesses,”…
Read MoreIn three separate suburban communities, people were arrested this week for possession of counterfeit drugs in the Washington, DC area and in Ohio suburbs. In Findlay, Ohio, Matthew Snodgrass, 23, faces charges of trafficking in drugs and counterfeit controlled substances, reports WFIN. Snodgrass is accused of selling ecstacy and a fake medication within 100 feet of a juvenile, and is…
Read MoreTwo men, driving two separate cargo trucks of medication disappeared on March 13th in Russia, as did their trucks and the cargo within them, after crossing the Russian border from Finland. The two men, aged 60 and 25, disappeared on March 13. Subsequently, the two trucks they were driving were found without license plates, empty of contents around St. Petersburg,…
Read More
The reality that key issues in healthcare go beyond geo-
political lines is evident by challenges associated with important public
health concerns. Pandemics, human-sourced disasters, drug safety, HIV-
AIDS and TB control and treatment all represent global circumstances
that require a wide array of stakeholder efforts to effectively address.
Simultaneously, a much broader range of global health organizations have
increasingly played a role in addressing these and other international
public health needs beyond traditional public health authorities.
Foundations, international agencies outside the health realm, and the
private sector have also become key participants in creating policies and
programs in an effort to promote global public health.
Hence, the Institute of Health Law Studies (IHLS) convened the 7th Annual
San Diego Health Policy Conference, entitled “Public-Private Partnerships
in Global Health.” The conference explored different models of public-
private partnerships emerging from the expansion of global health activities
to these larger bodies of groups, and will provide lessons for participants,
providers, and policymakers as to how to best engage these entities and
systems to most effectively and efficiently advance global health.
The reality that key issues in healthcare go beyond geo-
political lines is evident by challenges associated with important public
health concerns. Pandemics, human-sourced disasters, drug safety, HIV-
AIDS and TB control and treatment all represent global circumstances
that require a wide array of stakeholder efforts to effectively address.
Simultaneously, a much broader range of global health organizations have
increasingly played a role in addressing these and other international
public health needs beyond traditional public health authorities.
Foundations, international agencies outside the health realm, and the
private sector have also become key participants in creating policies and
programs in an effort to promote global public health.
Hence, the Institute of Health Law Studies (IHLS) convened the 7th Annual
San Diego Health Policy Conference, entitled “Public-Private Partnerships
in Global Health.” The conference explored different models of public-
private partnerships emerging from the expansion of global health activities
to these larger bodies of groups, and will provide lessons for participants,
providers, and policymakers as to how to best engage these entities and
systems to most effectively and efficiently advance global health.